Tombari Pius Monsi, Miriam Nkiruka Egeolu, Smart Enoch Amala, Lynda Kadi Giami and Samuel Douglas Abbey
In late December of 2019, a new type of viral disease was first detected in Wuhan, China which was quickly recognized as a novel coronavirus [1]. The similarity of the virus with Severe Acute Respiratory Syndrome-SRAS coronavirus lead it to be named SARS-CoV-2 and the disease was named COVID-19. The WHO declared it a pandemic on March 11th, 2020. According to worldometer’s real-time data, to date (October 4th, 2020) the number of infected people with SARS-CoV-2 is more than 352 million and 1.3 million deaths worldwide. (Coronavirus Update (Live)) This pandemic has put forward another long-term public health problem which is Antimicrobial Resistance (AMR), in this case, antibiotic resistance. To illustrate the importance of this problem, even in the middle of a pandemic, the World Health Organization’s Director-General addressed the issue of AMR as ‘one of the most urgent challenges of our time’ which has been further accelerated by the use of a huge amount of antibiotics during this pandemic (WHO news) [2,3].